JPS6141352B2 - - Google Patents
Info
- Publication number
- JPS6141352B2 JPS6141352B2 JP10764277A JP10764277A JPS6141352B2 JP S6141352 B2 JPS6141352 B2 JP S6141352B2 JP 10764277 A JP10764277 A JP 10764277A JP 10764277 A JP10764277 A JP 10764277A JP S6141352 B2 JPS6141352 B2 JP S6141352B2
- Authority
- JP
- Japan
- Prior art keywords
- compound
- acid
- reference example
- added
- nax
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 2
- 125000001511 cyclopentyl group Chemical class [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 42
- 150000001875 compounds Chemical class 0.000 description 27
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 18
- 239000000243 solution Substances 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 238000000034 method Methods 0.000 description 13
- 239000002904 solvent Substances 0.000 description 13
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 12
- 239000010410 layer Substances 0.000 description 11
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- -1 tetrahydropyranyl compound Chemical class 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 150000002596 lactones Chemical class 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 238000010898 silica gel chromatography Methods 0.000 description 5
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 150000004702 methyl esters Chemical class 0.000 description 4
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 3
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000012044 organic layer Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- MEKOFIRRDATTAG-UHFFFAOYSA-N 2,2,5,8-tetramethyl-3,4-dihydrochromen-6-ol Chemical compound C1CC(C)(C)OC2=C1C(C)=C(O)C=C2C MEKOFIRRDATTAG-UHFFFAOYSA-N 0.000 description 2
- BUDQDWGNQVEFAC-UHFFFAOYSA-N Dihydropyran Chemical compound C1COC=CC1 BUDQDWGNQVEFAC-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 125000003158 alcohol group Chemical group 0.000 description 2
- TWJVNKMWXNTSAP-UHFFFAOYSA-N azanium;hydroxide;hydrochloride Chemical class [NH4+].O.[Cl-] TWJVNKMWXNTSAP-UHFFFAOYSA-N 0.000 description 2
- SIPUZPBQZHNSDW-UHFFFAOYSA-N bis(2-methylpropyl)aluminum Chemical compound CC(C)C[Al]CC(C)C SIPUZPBQZHNSDW-UHFFFAOYSA-N 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- 150000001940 cyclopentanes Chemical class 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 150000002373 hemiacetals Chemical class 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 229940071870 hydroiodic acid Drugs 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002997 prostaglandinlike Effects 0.000 description 2
- 150000003180 prostaglandins Chemical class 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- QYCGBAJADAGLLK-UHFFFAOYSA-N 1-(cyclohepten-1-yl)cycloheptene Chemical compound C1CCCCC=C1C1=CCCCCC1 QYCGBAJADAGLLK-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- FMKNXQAUFDRBNP-UHFFFAOYSA-N CCCCCC(COP(O)=O)=O Chemical compound CCCCCC(COP(O)=O)=O FMKNXQAUFDRBNP-UHFFFAOYSA-N 0.000 description 1
- 239000012027 Collins reagent Substances 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- 108010079943 Pentagastrin Proteins 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IKWKJIWDLVYZIY-UHFFFAOYSA-M butyl(triphenyl)phosphanium;bromide Chemical compound [Br-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(CCCC)C1=CC=CC=C1 IKWKJIWDLVYZIY-UHFFFAOYSA-M 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 150000003983 crown ethers Chemical class 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 230000006196 deacetylation Effects 0.000 description 1
- 238000003381 deacetylation reaction Methods 0.000 description 1
- XXTZHYXQVWRADW-UHFFFAOYSA-N diazomethanone Chemical group [N]N=C=O XXTZHYXQVWRADW-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- NKRNGKIEDAVMHL-UHFFFAOYSA-L dihydroxy(dioxo)chromium;pyridine Chemical compound O[Cr](O)(=O)=O.C1=CC=NC=C1 NKRNGKIEDAVMHL-UHFFFAOYSA-L 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 125000000457 gamma-lactone group Chemical group 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000027119 gastric acid secretion Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 125000000686 lactone group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- ILSNISVKFYYCCE-UHFFFAOYSA-N methyl 2-cyclopentylacetate Chemical compound COC(=O)CC1CCCC1 ILSNISVKFYYCCE-UHFFFAOYSA-N 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 1
- ANRIQLNBZQLTFV-DZUOILHNSA-N pentagastrin Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1[C]2C=CC=CC2=NC=1)NC(=O)CCNC(=O)OC(C)(C)C)CCSC)C(N)=O)C1=CC=CC=C1 ANRIQLNBZQLTFV-DZUOILHNSA-N 0.000 description 1
- 229960000444 pentagastrin Drugs 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 229940127557 pharmaceutical product Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- NPRDHMWYZHSAHR-UHFFFAOYSA-N pyridine;trioxochromium Chemical compound O=[Cr](=O)=O.C1=CC=NC=C1.C1=CC=NC=C1 NPRDHMWYZHSAHR-UHFFFAOYSA-N 0.000 description 1
- 230000000580 secretagogue effect Effects 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- CWXOAQXKPAENDI-UHFFFAOYSA-N sodium methylsulfinylmethylide Chemical compound [Na+].CS([CH2-])=O CWXOAQXKPAENDI-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000013077 target material Substances 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
【発明の詳細な説明】
本発明はプロスタグランデイン類似化合物に関
するものである。即ち、本発明は一般式〔〕
〔式中、R1は水素原子あるいは低級アルキル基を
あらわし、R2は炭素原子数4〜8の低級アルキ
ル基をあらわす。〕
で表わされる新規なシクロペンタン誘導体に関す
るものである。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to prostaglandin-like compounds. That is, the present invention is based on the general formula [] [In the formula, R 1 represents a hydrogen atom or a lower alkyl group, and R 2 represents a lower alkyl group having 4 to 8 carbon atoms. ] This relates to a novel cyclopentane derivative represented by:
プロスタグランデインはその発見以来その多様
な薬理作用の点から、医薬品として注目され精力
的な研究がなされてきた。特に近年、新しい類似
化合物合成の試みとプロスタグランデインが持つ
ている多様な薬理作用の分離選択の試みがなされ
てきている。本発明の一般式〔〕で示されるプ
ロスタグランデイン類似化合物は、例えばヒスタ
ミンやペンタガストリンのような分泌促進剤によ
つて刺激を与えられた胃酸分泌を抑制するなど価
値ある薬理作用を示し、また、関連化合物では見
られる不快な副作用が欠けているという驚くべき
優位性を有している。 Since its discovery, prostaglandin has attracted attention as a pharmaceutical product due to its diverse pharmacological actions, and has been extensively researched. Particularly in recent years, attempts have been made to synthesize new analogous compounds and to isolate and select the various pharmacological actions possessed by prostaglandins. The prostaglandin-like compound of the present invention represented by the general formula [] exhibits valuable pharmacological effects, such as suppressing gastric acid secretion stimulated by secretagogues such as histamine and pentagastrin, and , which has the surprising advantage of lacking the unpleasant side effects seen with related compounds.
本発明の一般式〔〕で表わされる新規シクロ
ペンタン誘導体は例えば以下に示す方法で本発明
者等により初めて合成されたものである。 The novel cyclopentane derivative represented by the general formula [] of the present invention was synthesized for the first time by the present inventors, for example, by the method shown below.
〔図中、Tsはトシル基を示し、R3は低級アルキル
を示し、Acはアセチル基を示し、THPはテトラ
ヒドロピラニル基を示し、R1及びR2は前記と同
じ意味を有する。〕
即ち、文献公知の化合物(1)(テトラヘドロン
Tetrahedron、22、95(1966))をピリジン中ト
シルクロライドでトシル化し、化合物(2)とし、化
合物(2)をジメチルスルフオキサイド中青酸ナトリ
ウムと反応させ化合物(3)としたのち、化合物(3)の
シアノ基を加水分解し、化合物(4)とした。化合物
(4)をエステル化し化合物(5)とした後、二重結合を
酸化的に開裂し、化合物(6)とし化合物(6)のカルボ
ン酸を酸クロライドとし、ジアゾメタンと反応さ
せジアゾケトン体とした後、50%ヨウ化水素酸で
メチルケトン体(7)とした。化合物(7)はバイヤービ
リガー反応(Baeyer Billiger reaction)に付
し、ジアセテート体(8)とした。化合物(8)を酸性条
件下加熱するとラクトン体(9)が得られる。このも
のを無水酢酸と処理すると、アセテート体(10)が得
られる。化合物(10)のカルボン酸基をジボランで還
元し、アルコール体(11)とした後、コリンズ酸化
(Collin〓soxidation)に付し、アルデヒド体(12)と
した後、ヴイツテ化試剤と反応させエノーン体
(13)を得ることができる。エノーン体(13)の
カルボニル基をアルコール基に還元し(14)とし
た後、化合物(14)をアルカリ加水分解し、脱ア
セチル化の後、生成したヒドロキシル基をジヒド
ロピランと反応させて、ジテトラヒドロピラニル
体(15)としたのち、ラクトン基をジイソブチル
アルミニウムハイドライドで還元し、ヘミアセタ
ール体(16)とした後、ヴイツテイヒ試剤と反応
させ化合物(17)を得ることができる。化合物
(17)のヒドロキシ基を酸化した後、テトラヒド
ロピラニル基を弱酸により脱離せしめることによ
り前記一般式〔〕であらわされる化合物を得る
ことができる。 [In the figure, Ts represents a tosyl group, R 3 represents a lower alkyl group, Ac represents an acetyl group, THP represents a tetrahydropyranyl group, and R 1 and R 2 have the same meanings as above. ] That is, compound (1) (tetrahedron
Tetrahedron, 22 , 95 (1966)) was tosylated with tosyl chloride in pyridine to give compound (2), and compound (2) was reacted with sodium cyanide in dimethyl sulfoxide to give compound (3). ) was hydrolyzed to give compound (4). Compound
After esterifying (4) to form compound (5), the double bond is oxidatively cleaved to form compound (6), and the carboxylic acid of compound (6) is converted into an acid chloride, which is reacted with diazomethane to form a diazoketone form and 50% hydroiodic acid to obtain the methyl ketone body (7). Compound (7) was subjected to Baeyer Billiger reaction to form diacetate compound (8). When compound (8) is heated under acidic conditions, lactone (9) is obtained. When this is treated with acetic anhydride, the acetate (10) is obtained. The carboxylic acid group of compound (10) was reduced with diborane to form an alcohol form (11), which was then subjected to Collins oxidation to form an aldehyde form (12), which was then reacted with a Witzte conversion reagent to form an enone. body (13) can be obtained. After reducing the carbonyl group of enone compound (13) to alcohol group (14), compound (14) was subjected to alkaline hydrolysis, and after deacetylation, the generated hydroxyl group was reacted with dihydropyran to dilute After obtaining the tetrahydropyranyl compound (15), the lactone group is reduced with diisobutylaluminum hydride to obtain the hemiacetal compound (16), which is then reacted with Wittstein's reagent to obtain compound (17). After oxidizing the hydroxyl group of compound (17), the tetrahydropyranyl group is eliminated with a weak acid to obtain the compound represented by the above general formula [].
なお、本発明のR1およびR3で表わされる低級
アルキル基としてはメチル、エチル、プロピル等
が含まれ、炭素原子数4〜8の低級アルキル基と
しては、ブチル、ペンチル、ヘキシル、α−メチ
ル−ペンチル、α−α−ジメチル−ペンチル等が
含まれる。 In addition, the lower alkyl group represented by R 1 and R 3 in the present invention includes methyl, ethyl, propyl, etc., and the lower alkyl group having 4 to 8 carbon atoms includes butyl, pentyl, hexyl, α-methyl, etc. -pentyl, α-α-dimethyl-pentyl, and the like.
本発明によつてたとえば下記のような化合物を
得ることができる。 According to the present invention, for example, the following compounds can be obtained.
9−オキソ−11α−16−ジヒドロキシ−20−メ
チル−5−シス−14−トランス−プロスタジエン
酸 メチルエステル
9−オキソ−11α−16−ジヒドロキシ−17・20
−ジメチル−5−シス−14−トランス−プロスタ
ジエン酸 メチルエステル
9−オキソ−11α−16−ジヒドロキシ−17・
17・20−トリメチル−5−シス−14−トランス−
プロスタジエン酸 メチルエステル
9−オキソ−11α・16−ジヒドロキシ−17−エ
チル−20−メチル−5−シス−14−トランス−プ
ロスタジエン酸 メチルエステル
9−オキソ−11α・16−ジヒドロキシ−5−シ
ス−14−トランス−プロスタジエン酸 メチルエ
ステル
以下に実施例および参考例を挙げて本発明を具
体的に示すがもとより本発明はこれらに限定され
るものではない。 9-oxo-11α-16-dihydroxy-20-methyl-5-cis-14-trans-prostadienoic acid methyl ester 9-oxo-11α-16-dihydroxy-17・20
-dimethyl-5-cis-14-trans-prostadienoic acid methyl ester 9-oxo-11α-16-dihydroxy-17.
17・20-trimethyl-5-cis-14-trans-
Prostadienoic acid methyl ester 9-oxo-11α・16-dihydroxy-17-ethyl-20-methyl-5-cis-14-trans-Prostadienic acid methyl ester 9-oxo-11α・16-dihydroxy-5-cis- 14-trans-prostadienoic acid methyl ester The present invention will be specifically illustrated with reference to Examples and Reference Examples below, but the present invention is not limited thereto.
参考例 1
2−エキソ−シアノメチル−3−エンド−シア
ノメチル−ビシクロ〔2・2・1〕ヘプト−5
−エン
2−エキソ−ヒドロキシメチル−3−エンド−
ヒドロキシメチル−ビシクロ〔2・2・1〕ヘプ
ト−5−エン(3.08g)をピリジン(10ml)に溶
解し、この溶液に冷却下、p−トルエンスルホン
酸クロライド(7.7g)を無水ベンゼン(10ml)
に溶解し加えた。一晩室温下撹拌した後、ベンゼ
ン(100ml)を加え、ベンゼン層を水洗の後、10
%塩酸水、重曹水、水で洗い乾燥した。ベンゼン
層を留去し、ジトシレート(9g)を結晶として
得た。上記ジトシレート(9g)を無水ジメチル
スルフオキサイドに溶解し、青酸ナトリウム(4
g)を加え100℃で1.5時間加温した。ベンゼンと
水を加え、ベンゼン層を分液、水洗の後乾燥し
た。ベンゼンを留去し、目的の油状のジシアノ体
(3.1g)を得た。Reference example 1 2-exo-cyanomethyl-3-endo-cyanomethyl-bicyclo[2.2.1]hept-5
-ene 2-exo-hydroxymethyl-3-endo-
Hydroxymethyl-bicyclo[2.2.1]hept-5-ene (3.08 g) was dissolved in pyridine (10 ml), and p-toluenesulfonic acid chloride (7.7 g) was added to this solution under cooling in anhydrous benzene (10 ml). )
It was dissolved in and added. After stirring overnight at room temperature, benzene (100 ml) was added, the benzene layer was washed with water, and then
% hydrochloric acid solution, sodium bicarbonate solution, and water, and dried. The benzene layer was distilled off to obtain ditosylate (9 g) as crystals. The above ditosylate (9 g) was dissolved in anhydrous dimethyl sulfoxide, and sodium cyanide (4 g) was dissolved in anhydrous dimethyl sulfoxide.
g) was added and heated at 100°C for 1.5 hours. Benzene and water were added, and the benzene layer was separated, washed with water, and then dried. Benzene was distilled off to obtain the desired oily dicyano compound (3.1 g).
IRνfilm naxcm-1:2950、2250、1420、1340
NMR(CCl4)δ:6.0〜6.5(2H、m、olefinic
protons)
参考例 2
2−エキソ−3−エンド−ビスカルボメトキシ
メチル−ビシクロ〔2・2・1〕ヘプト−5−
エン
参考例1の方法で得られるジシアノ体(10g)
を20%苛性カリ水溶液中5時間加熱還流した後、
中性部をベンゼンで抽出した後、水層を10%塩酸
水で酸性とした後、酢酸エチルで酸部を抽出し
た。水洗後、乾燥し溶媒を留去し、融点162℃の
結晶であるカルボン酸を得た。この結晶を乾燥メ
タノールに溶解し、濃硫酸を少量加え、一晩撹拌
した後、重曹水を加え硫酸を中和した後、メタノ
ールを留去し、目的のジエステルをベンゼンで抽
出した。IRν film nax cm -1 : 2950, 2250, 1420, 1340 NMR (CCl 4 ) δ: 6.0 to 6.5 (2H, m, olefinic
Reference example 2 2-exo-3-endo-biscarbomethoxymethyl-bicyclo[2.2.1]hept-5-
Dicyano compound obtained by the method of Reference Example 1 (10g)
After heating under reflux for 5 hours in a 20% caustic potassium aqueous solution,
After extracting the neutral part with benzene, the aqueous layer was made acidic with 10% hydrochloric acid water, and then the acid part was extracted with ethyl acetate. After washing with water, it was dried and the solvent was distilled off to obtain a crystalline carboxylic acid with a melting point of 162°C. The crystals were dissolved in dry methanol, a small amount of concentrated sulfuric acid was added, and the mixture was stirred overnight. After neutralizing the sulfuric acid by adding aqueous sodium bicarbonate, the methanol was distilled off, and the desired diester was extracted with benzene.
蒸留により9.5gの目的物(b.p.106〜110℃/
0.2mmHg)を得た。 Distillation yields 9.5g of target material (bp106~110℃/
0.2mmHg).
IRνfilm naxcm-1:1740、1440、1150
NMR(CCl4)δ:5.8〜6.4(2H、m)、3.65
(6H、s)
参考例 3
1−α−アセチル−4−α−アセチル−2−α
−カルボメトキシメチル−3−β−カルボメト
キシメチル−シクロペンタン
参考例2の方法で得られるビシクロヘプテン−
ジエステル(10g)を無水ベンゼン(200ml)に
溶解し、クラウンエーテル(Crownether)(500
mg)及び過マンガン酸カリウム(22g)を加え室
温で一昼夜撹拌した後、水(50ml)を加え30分撹
拌した後析出部を去し、得た母液のベンゼン層
を分別し、水層を濃塩酸でPH1とした後、目的の
ジカルボン酸を酢酸エチルで抽出した。得量9.6
g前記ジカルボン酸(9.6g)を無水ベンゼン
(150ml)に懸濁させ、無水ジメチルホルムアミド
(1ml)を加え冷却下20%ホスゲン液(30ml)を
加えた後、反応混合物を室温で撹拌した後、ベン
ゼン層を分離し、濃縮によりカルボン酸クロライ
ドを得た。このものをジアゾメタンのエーテル溶
液中へエーテルに溶かして滴下し、3時間室温に
て撹拌した。エーテルを留去し、ビス−ジアゾケ
トン体を得た。このものをクロロホルム(70ml)
に溶解し、50%ヨウ化水素酸(10ml)を滴下し
た。クロロホルム層を水洗の後、乾燥し、得た粗
油状物をシリカゲルカラムクロマトグラフイーに
付し目的のジアセチル体(3.2g)を得た。IRν film nax cm -1 : 1740, 1440, 1150 NMR (CCl 4 ) δ: 5.8 to 6.4 (2H, m), 3.65
(6H, s) Reference example 3 1-α-acetyl-4-α-acetyl-2-α
-Carbomethoxymethyl-3-β-carbomethoxymethyl-cyclopentane Bicycloheptene obtained by the method of Reference Example 2-
Diester (10 g) was dissolved in anhydrous benzene (200 ml) and Crownether (500 g) was dissolved in anhydrous benzene (200 ml).
mg) and potassium permanganate (22 g) and stirred overnight at room temperature. After adding water (50 ml) and stirring for 30 minutes, the precipitate was removed, the benzene layer of the mother liquor obtained was separated, and the aqueous layer was concentrated. After adjusting the pH to 1 with hydrochloric acid, the desired dicarboxylic acid was extracted with ethyl acetate. Yield 9.6
g The above dicarboxylic acid (9.6 g) was suspended in anhydrous benzene (150 ml), anhydrous dimethylformamide (1 ml) was added, 20% phosgene solution (30 ml) was added under cooling, and the reaction mixture was stirred at room temperature. The benzene layer was separated and concentrated to obtain carboxylic acid chloride. This material was dissolved in ether and added dropwise to an ether solution of diazomethane, and the mixture was stirred at room temperature for 3 hours. The ether was distilled off to obtain a bis-diazoketone body. Add this to chloroform (70ml)
50% hydroiodic acid (10 ml) was added dropwise. The chloroform layer was washed with water and then dried, and the obtained crude oil was subjected to silica gel column chromatography to obtain the desired diacetyl compound (3.2 g).
IRνfilm naxcm-1:1740、1710、1440、1360、12
60
NMR(CCl4)δ:3.6(6H、s)、2.13(6H、
s)
参考例 4
1−α−アセトキシ−4−α−アセトキシ−2
−α−カルボメトキシメチル−3−β−カルボ
メトキシメチル−シクロペンタン
参考例3の方法で得られるジアセチル−シクロ
ペンタン誘導体(1.5g)をジクロルメタン(60
ml)に溶解し、燐酸1水素ナトリウム(6.7g)
を加え、この懸濁液に90%過酸化水素水(1.28
ml)と無水トリフルオロ酢酸(9.8g)とをジク
ロルメタン(20ml)に溶解した液を穏やかに還流
する速度で加えた。反応液を滴下後室温で2時間
撹拌した後、析出結晶を別し、クロロホルム洗
滌し、有機層は重曹水、水で洗つた後、乾燥し
た。溶媒を留去し、目的のジアセトキシ体(1.48
g)を油状物として得た。IRν film nax cm -1 : 1740, 1710, 1440, 1360, 12
60 NMR (CCl 4 ) δ: 3.6 (6H, s), 2.13 (6H,
s) Reference example 4 1-α-acetoxy-4-α-acetoxy-2
-α-Carbomethoxymethyl-3-β-carbomethoxymethyl-cyclopentane Diacetyl-cyclopentane derivative (1.5 g) obtained by the method of Reference Example 3 was mixed with dichloromethane (60 g).
ml) and sodium monohydrogen phosphate (6.7 g)
and to this suspension 90% hydrogen peroxide (1.28
ml) and trifluoroacetic anhydride (9.8 g) in dichloromethane (20 ml) were added at a rate of gentle reflux. After the reaction solution was added dropwise and stirred at room temperature for 2 hours, the precipitated crystals were separated and washed with chloroform, and the organic layer was washed with aqueous sodium bicarbonate and water, and then dried. The solvent was distilled off and the desired diacetoxy compound (1.48
g) was obtained as an oil.
IRνfilm naxcm-1:1740、1440、1370、1240、11
60、
1070、1020
NMR(CCl4)δ:4.7〜5.3(2H、m)、3.6(6H、
s)、2.0(6H、s)
参考例 5
2・4−α・α−ジヒドロキシ−5−β−カル
ボキシメチル−シクロペンタニル−α−酢酸
γ−ラクトン
参考例4の方法で得られる1・4−α・α−ジ
アセトキシ−2−カルボメトキシメチル−3−β
−カルボメトキシメチル−シクロペンタン(300
mg)を濃塩酸(2.0ml)中で2時間加熱した後、
減圧下水を留去し、得た残渣からエーテルで抽出
し、結晶性の目的物(160mg)を得た。IRν film nax cm -1 : 1740, 1440, 1370, 1240, 11
60,
1070, 1020 NMR (CCl 4 ) δ: 4.7-5.3 (2H, m), 3.6 (6H,
s), 2.0 (6H, s) Reference example 5 2,4-α・α-dihydroxy-5-β-carboxymethyl-cyclopentanyl-α-acetic acid
γ-Lactone 1,4-α,α-diacetoxy-2-carbomethoxymethyl-3-β obtained by the method of Reference Example 4
-carbomethoxymethyl-cyclopentane (300
mg) in concentrated hydrochloric acid (2.0 ml) for 2 hours, then
The water was distilled off under reduced pressure, and the resulting residue was extracted with ether to obtain the crystalline target product (160 mg).
IRνnujol naxcm-1:1780、1710、1420、1200、
1080、
1040
参考例 6
α−α−ヒドロキシ−4−α−アセトキシ−5
−β−カルボキシメチル−シクロペンタニル−
α−酢酸 γ−ラクトン
参考例5の方法で得られる2・4−α・α−ジ
ヒドロキシ−5−β−カルボキシメチル−シクロ
ペンタニル−α−酢酸 γ−ラクトン(100mg)
を無水酢酸と一晩撹拌した後、減圧下過剰の無水
酢酸及び生成した酢酸を留去し、得た残査から目
的のカルボン酸(105mg)をmp108〜110℃の結晶
として得た。IRν nujol nax cm -1 : 1780, 1710, 1420, 1200,
1080,
1040 Reference example 6 α-α-hydroxy-4-α-acetoxy-5
-β-carboxymethyl-cyclopentanyl-
α-acetic acid γ-lactone 2,4-α,α-dihydroxy-5-β-carboxymethyl-cyclopentanyl-α-acetic acid γ-lactone obtained by the method of Reference Example 5 (100 mg)
After stirring the mixture with acetic anhydride overnight, excess acetic anhydride and the acetic acid produced were distilled off under reduced pressure, and the desired carboxylic acid (105 mg) was obtained as crystals with a temperature of 108 to 110°C from the resulting residue.
IRνnujol nax(cm-1):1770、1740、1710、14
40、
1340、1230、1180、1040
参考例 7
2−α−ヒドロキシ−4−α−アセトキシ−5
−β−(2′−ヒドロキシ−エチル)−シクロペン
タニル−α−酢酸 γ−ラクトン
参考例6の方法で得られる2−α−ヒドロキシ
−4−α−アセトキシ−5−β−カルボキシメチ
ル−シクロペンタニル−α−酢酸 γ−ラクトン
(50mg)を過剰のジボランを含むテトラヒドロフ
ラン中0〜−10℃で1時間撹拌した後、過剰のジ
ボランをアセトンで消費した後、溶媒を減圧下留
去し、残渣にクロロホルムと飽和塩化アンモニウ
ム水を加え目的物を抽出した。溶媒を留去して、
目的のアルコール体(45mg)を油状物として得
た。IRν nujol nax (cm -1 ): 1770, 1740, 1710, 14
40,
1340, 1230, 1180, 1040 Reference example 7 2-α-hydroxy-4-α-acetoxy-5
-β-(2'-hydroxy-ethyl)-cyclopentanyl-α-acetic acid γ-lactone 2-α-hydroxy-4-α-acetoxy-5-β-carboxymethyl-cyclo obtained by the method of Reference Example 6 After stirring pentanyl-α-acetic acid γ-lactone (50 mg) in tetrahydrofuran containing excess diborane at 0 to -10°C for 1 hour, the excess diborane was consumed with acetone, and the solvent was distilled off under reduced pressure. Chloroform and saturated ammonium chloride water were added to the residue to extract the target product. By distilling off the solvent,
The desired alcohol (45 mg) was obtained as an oil.
IRνfilm naxcm-1:3450、1770、1730、1360、12
40、
1160、1020
NMR(CDl3)δ:4.8〜5.2(2H、m)、3.7(2H、
t)、2.0(3H、s)
参考例 8
2−α−ヒドロキシ−4−α−アセトキシ−5
−β−(4−オキソ−2−トランス−ノネニ
ル)−シクロペンタニル−α−酢酸 γ−ラク
トン
参考例7の方法で得られるアルコール誘導体
(50mg)をジクロルメタン(10ml)中、クロム酸
−ピリジンで酸化した後、エーテルを加え、析出
結晶を去し、得た液を濃縮し、目的の2−α
−ヒドロキシ−4−α−アセトキシ−5−β−ホ
ルミルメチル−シクロペンタニル−α−酢酸 γ
−ラクトンを油状物として得た。別途ジメチル−
2−オキソヘプチルフオスフオネートと50%水素
化ナトリウムとから調製された試剤を含むジメト
キシエタン溶液に室温下上記アルデヒド体を加
え、2時間撹拌した。少量の酢酸を加え中和した
後、溶媒を留去し、目的のエノン体をエーテル抽
出しエーテル溶媒留去後得た油状物をシリカゲル
クロマトグラフイーに付し目的物(65mg)を得
た。IRν film nax cm -1 : 3450, 1770, 1730, 1360, 12
40,
1160, 1020 NMR ( CDl3 ) δ: 4.8-5.2 (2H, m), 3.7 (2H,
t), 2.0 (3H, s) Reference example 8 2-α-hydroxy-4-α-acetoxy-5
-β-(4-oxo-2-trans-nonenyl)-cyclopentanyl-α-acetic acid γ-lactone The alcohol derivative (50 mg) obtained by the method of Reference Example 7 was diluted with chromic acid-pyridine in dichloromethane (10 ml). After oxidation, ether is added to remove the precipitated crystals, and the resulting liquid is concentrated to obtain the desired 2-α
-Hydroxy-4-α-acetoxy-5-β-formylmethyl-cyclopentanyl-α-acetic acid γ
- The lactone was obtained as an oil. Dimethyl separately
The above aldehyde compound was added at room temperature to a dimethoxyethane solution containing a reagent prepared from 2-oxoheptyl phosphonate and 50% sodium hydride, and the mixture was stirred for 2 hours. After neutralizing by adding a small amount of acetic acid, the solvent was distilled off, the desired enone was extracted with ether, and the oil obtained after distilling off the ether solvent was subjected to silica gel chromatography to obtain the desired product (65 mg).
IRνfilm naxcm-1:1770、1730、1700、1660、16
20、
1460、1360、1220、1040
参考例 9
2−α−ヒドロキシ−4−α−アセトキシ−5
−β−(4−ヒドロキシ−2−トランス−ノネ
ニル)−シクロペンタニル−α−酢酸 γ−ラ
クトン
参考例8の方法で得られるエノン体(50mg)を
無水メタノール中、氷冷下水素化ホウ素ナトリウ
ムと反応させ過剰の試剤をアセトンで消費した後
溶媒を留去し、得た残渣にエーテルと、飽和塩化
アンモニウム水を加え目的物をエーテルで抽出し
た。エーテル層を水洗後乾燥し、溶媒を留去し、
目的のアルコール体(45mg)を油状物として得
た。IRν film nax cm -1 : 1770, 1730, 1700, 1660, 16
20,
1460, 1360, 1220, 1040 Reference example 9 2-α-hydroxy-4-α-acetoxy-5
-β-(4-hydroxy-2-trans-nonenyl)-cyclopentanyl-α-acetic acid γ-lactone The enone form (50 mg) obtained by the method of Reference Example 8 was added to sodium borohydride in anhydrous methanol under ice cooling. After consuming the excess reagent with acetone, the solvent was distilled off, ether and saturated ammonium chloride water were added to the resulting residue, and the target product was extracted with ether. The ether layer was washed with water, dried, and the solvent was distilled off.
The desired alcohol (45 mg) was obtained as an oil.
IRνfilm naxcm-1:3500、1770、1730、1190、11
30、
1080
参考例 10
2−α−ヒドロキシ−4−α−ヒドロキシ−5
−β−(4−ヒドロキシ−2−トランス−ノネ
ニル)−シクロペンタニル−α−酢酸 γ−ラ
クトン
参考例9の方法で得られる4−α−アセトキシ
体(150mg)をメタノール(3ml)に溶解し炭酸
カリウム(50mg)を加えて室温で1時間撹拌し
た。IRν film nax cm -1 : 3500, 1770, 1730, 1190, 11
30,
1080 Reference example 10 2-α-hydroxy-4-α-hydroxy-5
-β-(4-hydroxy-2-trans-nonenyl)-cyclopentanyl-α-acetic acid γ-lactone The 4-α-acetoxy compound (150 mg) obtained by the method of Reference Example 9 was dissolved in methanol (3 ml). Potassium carbonate (50 mg) was added and stirred at room temperature for 1 hour.
反応混合物を1N塩酸で中和し、減圧下メタノ
ールを留去し、目的物を酢酸エチルで抽出した。
その抽出液を塩水で洗つた後乾燥した。溶媒を留
去して得た油状物をシリカゲルカラムクロマトグ
ラフイーに付し、ベンゼン−酢酸エチル(1:
3)の溶出部より、目的のジオールラクトン体
(112mg)を油状物として得た。 The reaction mixture was neutralized with 1N hydrochloric acid, methanol was distilled off under reduced pressure, and the desired product was extracted with ethyl acetate.
The extract was washed with brine and then dried. The oily substance obtained by distilling off the solvent was subjected to silica gel column chromatography, and benzene-ethyl acetate (1:
The target diol lactone (112 mg) was obtained as an oil from the elution portion of 3).
IRνfilm nax(cm-1):3400、3060、2950、2850
、
1770、1460、1380、1340、1260、1180
参考例 11
2−α−ヒドロキシ−4−α−テトラヒドロピ
ラニルオキシ−5−β−(4−テトラヒドロピ
ラニルオキシ−2−トランス−ノネニル)−シ
クロペンタニル−α−酢酸 γ−ラクトン
参考例10の方法で得られるジオール体(110
mg)をジクロルメタン(2ml)に溶解し、その溶
液をジヒドロピラン(50mg)とp−トルエンスル
ホン酸(10mg)と室温下30分間反応させた。IRν film nax (cm -1 ): 3400, 3060, 2950, 2850
,
1770, 1460, 1380, 1340, 1260, 1180 Reference example 11 2-α-hydroxy-4-α-tetrahydropyranyloxy-5-β-(4-tetrahydropyranyloxy-2-trans-nonenyl)-cyclopenta Nyl-α-acetic acid γ-lactone Diol compound obtained by the method of Reference Example 10 (110
mg) was dissolved in dichloromethane (2 ml), and the solution was reacted with dihydropyran (50 mg) and p-toluenesulfonic acid (10 mg) at room temperature for 30 minutes.
反応混合物を重炭酸ナトリウム水溶液で中和
し、酢酸エチルで希釈し水と塩化ナトリウム水溶
液で洗滌し、減圧濃縮して目的とするテトラヒド
ロピラニル体(113mg)を得た。 The reaction mixture was neutralized with an aqueous sodium bicarbonate solution, diluted with ethyl acetate, washed with water and an aqueous sodium chloride solution, and concentrated under reduced pressure to obtain the desired tetrahydropyranyl compound (113 mg).
IRνfilm nax(cm-1):2950、1775、1490
参考例 12
9α−ヒドロキシ−11α−16−ビス(テトラヒ
ドロピラニルオキシ)−20−メチル−5−シス
−14−トランス−プロストジエン酸 メチルエ
ステル
参考例11の方法で得られるテトラヒドロピラニ
ル体(100mg)を無水トルエン(5ml)に溶解
し、−70℃で15%ジイソブチルアルミニウムハイ
ドライド(トルエン溶液3ml)を滴下した。同温
度で30分間撹拌した後メタノールをガスが発生し
なくなるまでゆるやかに滴下した。反応混合物の
温度を0℃に上げ、水(1ml)を加え30分間撹拌
した。その混合物を過して沈殿した水酸化アル
ミニウムを除去し、その液を分液し、有機層は
食塩水で洗滌し、硫酸マグネシウムで乾燥した。
溶媒を留去し、油状のヘミアセタール(93mg)を
得た。IRν film nax (cm -1 ): 2950, 1775, 1490 Reference example 12 9α-hydroxy-11α-16-bis(tetrahydropyranyloxy)-20-methyl-5-cis-14-trans-prostodienoic acid methyl ester The tetrahydropyranyl compound (100 mg) obtained by the method of Reference Example 11 was dissolved in anhydrous toluene (5 ml), and 15% diisobutylaluminum hydride (3 ml of toluene solution) was added dropwise at -70°C. After stirring at the same temperature for 30 minutes, methanol was slowly added dropwise until no gas was generated. The temperature of the reaction mixture was raised to 0°C, water (1 ml) was added, and the mixture was stirred for 30 minutes. The mixture was filtered to remove precipitated aluminum hydroxide, the solution was separated into layers, and the organic layer was washed with brine and dried over magnesium sulfate.
The solvent was distilled off to obtain oily hemiacetal (93 mg).
ジメチルスルフオキシド(10ml)に水酸化ナト
リウム(50%、96mg)を加え、70〜75℃1時間加
温し、ナトリウムメチルスルフイニルメチリドを
調製し、20℃に保ちながら、4−カルボキシ−n
−ブチルトリフエニルホスホニウムブロマイド
(443mg)のジメチルスルフオキシド(5ml)溶液
を加えた。5分間撹拌した後、上で得た、ヘミア
セタールのジメチルスルフオキシド(2ml)溶液
を加え室温で3時間撹拌した。 Sodium hydroxide (50%, 96 mg) was added to dimethyl sulfoxide (10 ml) and heated at 70-75°C for 1 hour to prepare sodium methylsulfinyl methylide. -n
-A solution of butyl triphenylphosphonium bromide (443 mg) in dimethyl sulfoxide (5 ml) was added. After stirring for 5 minutes, a solution of hemiacetal in dimethyl sulfoxide (2 ml) obtained above was added, and the mixture was stirred at room temperature for 3 hours.
反応混合液に酢酸エチルと水を加え、有機層を
分離して得た水層を希塩酸でPH1とした後、目的
物を酢酸エチルで抽出した。 Ethyl acetate and water were added to the reaction mixture, the organic layer was separated, the resulting aqueous layer was adjusted to pH 1 with diluted hydrochloric acid, and the desired product was extracted with ethyl acetate.
溶媒を留去して得た油状物を少量のテトラヒド
ロフランに溶解し、ジアゾメタンを含むエーテル
溶液を加えメチルエステル化した。溶媒を留去後
得た油状物をシリカゲルカラムクロマトグラフイ
ーに付し、目的の掲題化合物(98mg)を得た。 The oil obtained by distilling off the solvent was dissolved in a small amount of tetrahydrofuran, and an ether solution containing diazomethane was added to methyl esterify it. The oil obtained after evaporating the solvent was subjected to silica gel column chromatography to obtain the desired title compound (98 mg).
IRνfilm nax(cm-1):3350、2930、1735、1280
実施例 1
9−オキソ−11α−16−ジヒドロオキシ−20−
メチル−5−シス−14−トランス−プロストジ
エン酸 メチルエステル
参考例12の方法で得られる9α−ヒドロキシ−
11α−16−ビス(テトラヒドロピラニルオキシ)
−20−メチル−5−シス−14−トランス−プロス
トジエン酸 メチルエステル(95mg)をジクロル
メタンに溶解し2倍当量のコリンズ試薬
(Collins reagent)を含むジクロルメタン溶液に
加え室温で10分間撹拌した。無水エーテルを加え
析出したクロム酸を珪藻土を使用し、去した後
濃縮すると、粗9−オキソ−11α−16−ビス−
(テトラヒドロピラニルオキシ)−20−メチル−5
−シス−14−テトランス−プロスタジエン酸 メ
チルエステル(88mg)を得た。IRν film nax (cm -1 ): 3350, 2930, 1735, 1280 Example 1 9-oxo-11α-16-dihydroxy-20-
Methyl-5-cis-14-trans-prostodienoic acid methyl ester 9α-hydroxy obtained by the method of Reference Example 12
11α-16-bis(tetrahydropyranyloxy)
-20-Methyl-5-cis-14-trans-prostodienoic acid methyl ester (95 mg) was dissolved in dichloromethane, added to a dichloromethane solution containing two equivalents of Collins reagent, and stirred at room temperature for 10 minutes. After adding anhydrous ether and removing the precipitated chromic acid using diatomaceous earth, the crude 9-oxo-11α-16-bis-
(tetrahydropyranyloxy)-20-methyl-5
-cis-14-tetrans-prostadienoic acid methyl ester (88 mg) was obtained.
IRνfilm nax(cm-1):3450、2950、1740、1280
上記化合物を酢酸:テトラヒドロフラン:水
(65:10:35)の混合液(10ml)に溶解し45℃で
3時間撹拌した。反応液を減圧濃縮して、残留物
に酢酸エチルを加え抽出し、食塩水洗いの後、溶
媒留去後、得た油状物をシリカゲルカラムクロマ
トグラフイーに付し、目的の掲題化合物を得た。IRν film nax (cm -1 ): 3450, 2950, 1740, 1280 The above compound was dissolved in a mixture (10 ml) of acetic acid:tetrahydrofuran:water (65:10:35) and stirred at 45°C for 3 hours. The reaction solution was concentrated under reduced pressure, and the residue was extracted with ethyl acetate. After washing with brine and evaporating the solvent, the obtained oil was subjected to silica gel column chromatography to obtain the desired title compound.
IRνfilm nax(cm-1):3450、2995、2950、1740
、
1730、1480、1380、1250IRν film nax (cm -1 ): 3450, 2995, 2950, 1740
,
1730, 1480, 1380, 1250
Claims (1)
あらわし、R2は炭素原子数4〜8の低級アルキ
ル基を表わす。〕 で表わされる新規シクロペンタン誘導体。[Claims] 1. General formula [In the formula, R 1 represents a hydrogen atom or a lower alkyl group, and R 2 represents a lower alkyl group having 4 to 8 carbon atoms. ] A novel cyclopentane derivative represented by
Priority Applications (9)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10764277A JPS5441849A (en) | 1977-09-06 | 1977-09-06 | Novel cyclopentane derivative |
GB42937/79A GB1595119A (en) | 1977-05-31 | 1978-05-26 | 2-hydroxycyclopentaneacetic acid y-lactones and processes for producing them |
GB23537/78A GB1595118A (en) | 1977-05-31 | 1978-05-26 | Prostadienoic acids processes for producing them and compositions containing them |
US05/911,039 US4210669A (en) | 1977-05-31 | 1978-05-30 | Prostanoic acid derivatives |
FR7816094A FR2392973A1 (en) | 1977-05-31 | 1978-05-30 | PROSTANOIC ACID DERIVATIVES, THEIR PREPARATION AND THEIR USE AS ANTI-ULCEROSE MEDICINAL PRODUCT |
CH589178A CH637377A5 (en) | 1977-05-31 | 1978-05-30 | PROSTANIC ACID DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS. |
DE19782823551 DE2823551A1 (en) | 1977-05-31 | 1978-05-30 | PROSTANIC ACID DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS |
CA000304456A CA1117109A (en) | 1977-05-31 | 1978-05-30 | Prostanoic acid derivatives |
US06/039,215 US4233222A (en) | 1977-05-31 | 1979-05-15 | Cyclopentylacetic acid derivatives |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10764277A JPS5441849A (en) | 1977-09-06 | 1977-09-06 | Novel cyclopentane derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5441849A JPS5441849A (en) | 1979-04-03 |
JPS6141352B2 true JPS6141352B2 (en) | 1986-09-13 |
Family
ID=14464359
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10764277A Granted JPS5441849A (en) | 1977-05-31 | 1977-09-06 | Novel cyclopentane derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5441849A (en) |
-
1977
- 1977-09-06 JP JP10764277A patent/JPS5441849A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5441849A (en) | 1979-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6121216B2 (en) | ||
EP0060640A1 (en) | 5,6,7-Trinor-4,8-inter-m-phenylene PGI derivatives and pharmaceutical compositions containing them | |
JPH0324457B2 (en) | ||
JPH0451538B2 (en) | ||
EP0156611B1 (en) | Intermediates for the preparation of prostaglandin analogues | |
JPS6141352B2 (en) | ||
JPS624390B2 (en) | ||
JPH0414091B2 (en) | ||
JPS6125010B2 (en) | ||
JPS60169459A (en) | Manufacture of phenoxyprostatrienoic acid derivative | |
JPH0446256B2 (en) | ||
NO160846B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTICALLY ACTIVE CARBACYCLINES. | |
US4210669A (en) | Prostanoic acid derivatives | |
JPS6022708B2 (en) | Prostaglandin-like compounds | |
JPH0463056B2 (en) | ||
US4508913A (en) | Dialkoxymethyl-butyrolactones | |
JPS6228134B2 (en) | ||
JPS59144753A (en) | Fluoroprostaglandin and manufacture | |
US4097494A (en) | Novel cyclopentanones | |
JPS6236031B2 (en) | ||
KR840001722B1 (en) | Process for the preparation of prostaglandin derivative | |
JPS6131107B2 (en) | ||
JPS5946946B2 (en) | Method for producing cyclopentanone derivative compounds | |
NO163225B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3-OXA-5-FLUORCARBACYCLINE DERIVATIVES. | |
JPS6223737B2 (en) |